Can a smartphone app improve healthcare for new parents and babies?

NCT ID NCT05595486

Completed Knowledge-focused Sponsor: Women and Infants Hospital of Rhode Island Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a mobile app called Baby2Home designed to help new families get the healthcare they need after childbirth. Over 600 parents and their babies took part, with some using the app and others getting usual care. The goal was to see if the app improved checkups, vaccines, and mental health screening for both parents and infants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Baby2Home mobile health application
What this could lead to: If successful, this app could help new parents and babies get better preventive care, like checkups and vaccines, and reduce gaps in care for different groups.
What could go wrong: This is a completed trial, but the app may not work for everyone, especially those without smartphones or English skills. Results may not apply to all families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 PANDEMIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior COVID-19 perinatal asphyxia postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 PANDEMIC HEALTH KNOWLEDGE, ATTITUDES, PRACTICE MENTAL HEALTH WELLNESS PERINATAL DEPRESSION POST PARTUM DEPRESSION

Contacts and locations

Locations

Northwestern Medicine Prentice Women's Hospital

Chicago, Illinois, 60611, United States
Women and Infant's Hospital

Providence, Rhode Island, 02905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.